At this time, posts about Syntekabio are rapidly increasing on portals and securities communities, while foreign investors are tentatively recorded to have sold a net 6,800 shares today. Syntekabio is known as a genomic big data research company.


As of 11:30 AM on the 11th, Syntekabio's stock price is 29,750 KRW, up 7.79% from the previous day, with a trading volume of 2,618,204 shares, which is about 39.36% of the 5-day average trading volume. On September 7, Syntekabio became a market issue with the headline "Continuous rise due to confirmation of the efficacy of COVID-19 treatment candidate substances."


In addition to Syntekabio, posts by investors are also surging for DB HiTek1 Preferred (000995), Daelim Industrial (000210), and Green Cross Wellbeing (234690).



※Source: AI Investment Assistant AI Rassi


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing